Tata 1mg Labs Achieves 99.48% Score in CAP Proficiency Testing, Setting New Standards for Diagnostic Excellence

Tata 1mg Labs, a leader in diagnostic excellence, is proud to announce that it has achieved an outstanding score of 99.48% in the College of American Pat...

July 25, 2024 | Thursday | News
Kronos Bio Initiates Dosing of First Patient in Expansion Cohort with KB-0742 for High-Grade Serous Ovarian Cancer

Kronos Bio, a company dedicated to developing small molecule therapeutics that address cancers and other diseases driven by deregulated transcription, to...

July 24, 2024 | Wednesday | News
Bio-Rad Laboratories Announces Strategic Advances in Life Science and Clinical Diagnostics

Bio-Rad Laboratories, Inc., a global leader in life science research and clinical diagnostic products,  provides an overview of advances supporting th...

July 24, 2024 | Wednesday | News
Varian Receives FDA Clearance for Enhanced Ethos 2.0 Therapy System, Streamlining Adaptive Radiotherapy

Varian, a Siemens Healthineers company, has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for new functionality to its ...

July 23, 2024 | Tuesday | News
Johnson & Johnson Seeks FDA Approval for SPRAVATO® Nasal Spray as Monotherapy for Treatment-Resistant Depression

Johnson & Johnson  announced  the submission of a supplemental New Drug Application (sNDA) to the U.S. Food and Drug Administration (FDA) s...

July 23, 2024 | Tuesday | News
Valneva Secures $41.3 Million from CEPI and EU to Expand Access to Chikungunya Vaccine IXCHIQ®

Valneva to receive up to $41.3 million from CEPI and the European Union to expand access to chikungunya vaccine, IXCHIQ® Funding will support clin...

July 22, 2024 | Monday | News
GC Cell and Checkpoint Therapeutics Announce Collaboration to Explore Synergistic Cancer Therapies

Collaboration explores the potential synergistic effects of Checkpoint’s anti-PD-L1, cosibelimab, in combination with the autologous T cell thera...

July 16, 2024 | Tuesday | News
BioArctic AB’s Partner Eisai Announces Approval of Leqembi® (樂意保®) for Alzheimer’s Disease Treatment in Hong Kong

BioArctic AB  is pleased to announce that its partner, Eisai, has received approval from the Department of Health in Hong Kong for Leqembi® (bra...

July 11, 2024 | Thursday | News
HepaRegeniX Secures €15M Series C Funding to Advance Liver Regeneration Therapy HRX-215

Funds to support Phase Ib clinical trial of HRX-215 in the US and an international multicenter Phase IIa clinical trial in liver regeneration Elias Pa...

July 10, 2024 | Wednesday | News
Roche Receives CE Mark for Accu-Chek® SmartGuide CGM Solution, Empowering Diabetes Management in Europe

Roche  announced  that it has received the CE Mark for its Accu-Chek® SmartGuide continuous glucose monitoring (CGM) solution. This signifi...

July 09, 2024 | Tuesday | News
Apriori Bio Secures $1.1 Million from CEPI to Enhance AI-Driven Vaccine Platform Against Evolving Viruses

Biotechnology company Apriori Bio has been awarded US $1.1 million from CEPI to advance its biology-informed artificial intelligence platform Octavi...

July 09, 2024 | Tuesday | News
Rafarma Pharmaceuticals and Woods Medical Care to Establish Joint Industrial Venture in South Korea's Busan Technology Park

Rafarma Pharmaceuticals is pleased to announce the signing of a preliminary agreement to establish a joint industrial venture in Busan Technology Park (S...

July 04, 2024 | Thursday | News
Ecolab Launches First-Ever 100% Plastic-Free Disinfectant Wipe for Hospitals

Ecolab solutions help clean 15 million patient rooms and 3.5 billion surgical instruments. To help healthcare providers deliver a clean and safe enviro...

July 04, 2024 | Thursday | News
Dawn Health Partners with Merck to Develop Digital Solution for Growth Hormone Disorders

Dawn Health, the digital health company pioneering patient-first innovation, has announced they are working with leading global pharmaceutical company, M...

July 01, 2024 | Monday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2024 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close